on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Spire Healthcare
The Vanguard Group, Inc. has released a Form 8.3 showing its interest in Spire Healthcare Group plc. As of 16 October 2025, Vanguard holds 14,375,402 ordinary shares, representing 3.57% of Spire's issued share capital. This disclosure highlights Vanguard's significant investment in the healthcare company.
The disclosure includes details on Vanguard's purchase and sale activities. On record, the firm purchased 1,758 shares and sold 2,312 shares of Spire, both at the price of 2.40 GBP per unit. There are no cash-settled or stock-settled derivative transactions reported. Additionally, no new securities have been subscribed.
No indemnities, options, or other arrangements were entered into, indicating a clear investment position by Vanguard without further obligations or agreements with other parties. The disclosure was formally announced on 17 October 2025.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news